Published in Arch Dermatol on September 01, 2005
Topical calcineurin inhibitors in systemic lupus erythematosus. Ther Clin Risk Manag (2010) 0.80
Update on the use of topical calcineurin inhibitors in cutaneous lupus erythematosus. Biologics (2011) 0.78
Four cases of facial discoid lupus erythematosus successfully treated with topical pimecrolimus or tacrolimus. Ann Dermatol (2010) 0.75
Cloning and characterization of the common fragile site FRA6F harboring a replicative senescence gene and frequently deleted in human tumors. Oncogene (2002) 5.40
Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation. Proc Natl Acad Sci U S A (2005) 3.16
Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss. Nat Genet (2011) 3.16
Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon. Clin Cancer Res (2005) 2.98
A role for common fragile site induction in amplification of human oncogenes. Cancer Cell (2002) 2.63
Alterations in the common fragile site gene Parkin in ovarian and other cancers. Oncogene (2003) 2.44
Loss of HSulf-1 up-regulates heparin-binding growth factor signaling in cancer. J Biol Chem (2003) 2.40
Gene expression profiles predict early relapse in ovarian cancer after platinum-paclitaxel chemotherapy. Clin Cancer Res (2005) 2.29
Malignant pheochromocytoma: current status and initiatives for future progress. Endocr Relat Cancer (2004) 2.20
Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. Oncogene (2002) 2.16
3' tag digital gene expression profiling of human brain and universal reference RNA using Illumina Genome Analyzer. BMC Genomics (2009) 2.12
Mediastinal lymph node staging: from noninvasive to surgical. AJR Am J Roentgenol (2012) 2.02
Long, abundantly expressed non-coding transcripts are altered in cancer. Hum Mol Genet (2007) 2.00
Common fragile sites are preferential targets for HPV16 integrations in cervical tumors. Oncogene (2003) 2.00
Mutations in CHEK2 associated with prostate cancer risk. Am J Hum Genet (2003) 1.96
Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas. Blood (2012) 1.96
hSulf1 Sulfatase promotes apoptosis of hepatocellular cancer cells by decreasing heparin-binding growth factor signaling. Gastroenterology (2004) 1.95
Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing. Blood (2010) 1.90
Tumor transcriptome sequencing reveals allelic expression imbalances associated with copy number alterations. PLoS One (2010) 1.85
HSulf-1 modulates HGF-mediated tumor cell invasion and signaling in head and neck squamous carcinoma. Oncogene (2004) 1.82
Dysregulated microRNAs and their predicted targets associated with endometrioid endometrial adenocarcinoma in Hong Kong women. Int J Cancer (2009) 1.68
AGR2, an androgen-inducible secretory protein overexpressed in prostate cancer. Genes Chromosomes Cancer (2005) 1.58
Acquisition of high-level chromosomal instability is associated with integration of human papillomavirus type 16 in cervical keratinocytes. Cancer Res (2004) 1.56
MANF: a new mesencephalic, astrocyte-derived neurotrophic factor with selectivity for dopaminergic neurons. J Mol Neurosci (2003) 1.54
A candidate tumor suppressor HtrA1 is downregulated in ovarian cancer. Oncogene (2004) 1.47
Tumors and tumorlike conditions of the large airways. AJR Am J Roentgenol (2013) 1.45
FusionHunter: identifying fusion transcripts in cancer using paired-end RNA-seq. Bioinformatics (2011) 1.41
High detection rates of colorectal neoplasia by stool DNA testing with a novel digital melt curve assay. Gastroenterology (2008) 1.34
Genome-wide gene expression profiling of cervical cancer in Hong Kong women by oligonucleotide microarray. Int J Cancer (2006) 1.32
Human TopBP1 ensures genome integrity during normal S phase. Mol Cell Biol (2005) 1.31
Identification of underexpressed genes in early- and late-stage primary ovarian tumors by suppression subtraction hybridization. Cancer Res (2002) 1.29
Epigenetic silencing of TCEAL7 (Bex4) in ovarian cancer. Oncogene (2005) 1.24
Biallelic methylation and silencing of paternally expressed gene 3 (PEG3) in gynecologic cancer cell lines. Gynecol Oncol (2005) 1.24
The common fragile site FRA16D and its associated gene WWOX are highly conserved in the mouse at Fra8E1. Genes Chromosomes Cancer (2002) 1.22
LSINCT5 is over expressed in breast and ovarian cancer and affects cellular proliferation. RNA Biol (2011) 1.21
Characterization of FRA6E and its potential role in autosomal recessive juvenile parkinsonism and ovarian cancer. Genes Chromosomes Cancer (2003) 1.21
Identification of long stress-induced non-coding transcripts that have altered expression in cancer. Genomics (2010) 1.17
Preferential integration of human papillomavirus type 18 near the c-myc locus in cervical carcinoma. Oncogene (2003) 1.13
Transcriptional repression of WEE1 by Kruppel-like factor 2 is involved in DNA damage-induced apoptosis. Oncogene (2005) 1.12
Role of decreased levels of lipid phosphate phosphatase-1 in accumulation of lysophosphatidic acid in ovarian cancer. Clin Cancer Res (2003) 1.12
Mechanisms of genomic instabilities underlying two common fragile-site-associated loci, PARK2 and DMD, in germ cell and cancer cell lines. Am J Hum Genet (2010) 1.10
The clinical course of diffuse idiopathic pulmonary neuroendocrine cell hyperplasia. Chest (2015) 1.10
Headcheese sign. J Thorac Imaging (2014) 1.07
Dysregulated microRNAs in the pathogenesis and progression of cervical neoplasm. Cell Cycle (2012) 1.06
"Reversed halo sign". J Thorac Imaging (2011) 1.05
Parkin gene alterations in hepatocellular carcinoma. Genes Chromosomes Cancer (2004) 1.05
Tumorlike conditions of the pleura. Radiographics (2012) 1.03
Innovative uses of rituximab in dermatology. Dermatol Clin (2010) 0.98
Evidence that instability within the FRA3B region extends four megabases. Oncogene (2002) 0.98
Common and uncommon manifestations of Wegener granulomatosis at chest CT: radiologic-pathologic correlation. Radiographics (2012) 0.98
Aspiration-related lung diseases. J Thorac Imaging (2014) 0.97
The role of viral integration in the development of cervical cancer. Cancer Genet Cytogenet (2005) 0.96
Psychological distress (depression and anxiety) in people with head and neck cancers. Med J Aust (2010) 0.96
Adalimumab treatment for pyoderma gangrenosum. Arch Dermatol (2007) 0.96
Very large common fragile site genes and their potential role in cancer development. Cell Mol Life Sci (2014) 0.96
Induction of tumorigenesis and metastasis by the murine orthologue of tumor protein D52. Mol Cancer Res (2007) 0.95
Genome-wide characterization of transcriptional patterns in high and low antibody responders to rubella vaccination. PLoS One (2013) 0.95
Transcriptional profiling by sequencing of oropharyngeal cancer. Mayo Clin Proc (2012) 0.94
Human papillomavirus-associated oropharyngeal squamous cell carcinomas: primary tumor burden and survival in surgical patients. Ann Otol Rhinol Laryngol (2009) 0.94
Characterization of the common fragile site FRA9E and its potential role in ovarian cancer. Oncogene (2003) 0.94
Recalcitrant cutaneous sarcoidosis responding to infliximab. Arch Dermatol (2005) 0.93
Host genetic polymorphism analysis in cervical cancer. Clin Chem (2002) 0.93
Relationship between FRA11F and 11q13 gene amplification in oral cancer. Genes Chromosomes Cancer (2007) 0.93
Molecular characterization of endometrial cancer: a correlative study assessing microsatellite instability, MLH1 hypermethylation, DNA mismatch repair protein expression, and PTEN, PIK3CA, KRAS, and BRAF mutation analysis. Int J Gynecol Pathol (2012) 0.92
Off-label uses of biologics in dermatology: rituximab, omalizumab, infliximab, etanercept, adalimumab, efalizumab, and alefacept (part 2 of 2). J Am Acad Dermatol (2006) 0.90
Next-generation sequencing: a transformative tool for vaccinology. Expert Rev Vaccines (2009) 0.88
Vitiligo after the resolution of psoriatic plaques during treatment with adalimumab. J Am Acad Dermatol (2008) 0.88
Off-label uses of rituximab in dermatology. Dermatol Ther (2007) 0.88
Adalimumab for treatment of cutaneous sarcoidosis. Arch Dermatol (2006) 0.88
Nephrogenic systemic fibrosis: a review. J Drugs Dermatol (2010) 0.87
Safety and efficacy of tacrolimus ointment versus pimecrolimus cream in the treatment of patients with atopic dermatitis previously treated with corticosteroids. Acta Derm Venereol (2010) 0.87
Nonscarring inflammatory alopecia associated with the epidermal growth factor receptor inhibitor gefitinib. J Am Acad Dermatol (2006) 0.87
Successful treatment of mucous membrane pemphigoid with etanercept in 3 patients. Arch Dermatol (2006) 0.87
Discovering novel phenotype-selective neurotrophic factors to treat neurodegenerative diseases. Prog Brain Res (2004) 0.86
Positioning of cervical carcinoma and Burkitt lymphoma translocation breakpoints with respect to the human papillomavirus integration cluster in FRA8C at 8q24.13. Cancer Genet Cytogenet (2004) 0.86
"Septal bounce". J Thorac Imaging (2012) 0.86
Galaxy sign. J Thorac Imaging (2012) 0.86
CT scan findings of probable usual interstitial pneumonitis have a high predictive value for histologic usual interstitial pneumonitis. Chest (2015) 0.86
Imaging of granulomatous fibrosing mediastinitis. AJR Am J Roentgenol (2012) 0.85
A selected group of large common fragile site genes have decreased expression in oropharyngeal squamous cell carcinomas. Genes Chromosomes Cancer (2014) 0.84
Disabled-1 is a large common fragile site gene, inactivated in multiple cancers. Genes Chromosomes Cancer (2008) 0.84
ACR appropriateness Criteria® radiographically detected solitary pulmonary nodule. J Thorac Imaging (2013) 0.82
Identification of submicroscopic genetic changes and precise breakpoint mapping in myelofibrosis using high resolution mate-pair sequencing. Am J Hematol (2013) 0.81
A case of CD56+ mycosis fungoides. Arch Dermatol (2006) 0.81
Assembly intermediates in polyketide biosynthesis: enantioselective syntheses of beta-hydroxycarbonyl compounds. Org Biomol Chem (2005) 0.80
Off-label uses of biologic agents in dermatology: a 2006 update. Semin Cutan Med Surg (2006) 0.80
Total synthesis of unguisin A. J Org Chem (2011) 0.80
Linking expression of FOXM1, CEP55 and HELLS to tumorigenesis in oropharyngeal squamous cell carcinoma. Laryngoscope (2011) 0.79
ACR appropriateness criteria(®)acute respiratory illness in immunocompromised patients. J Am Coll Radiol (2012) 0.79
Human Papillomavirus and the Development of Different Cancers. Cytogenet Genome Res (2017) 0.78
ACR appropriateness criteria® hemoptysis. J Thorac Imaging (2014) 0.78
Image noise and liver lesion detection with MDCT: a phantom study. AJR Am J Roentgenol (2011) 0.78
Radiological approach to interstitial lung disease: a guide for the nonradiologist. Clin Chest Med (2012) 0.78
4-Dimensional cardiac magnetic resonance in a patient with bicuspid pulmonic valve: characterization of post-stenotic flow. J Am Coll Cardiol (2012) 0.78
Expression profiles of viral responsive genes in oral and oropharyngeal cancers. Eur J Cancer (2010) 0.78
Embryology and developmental defects of the interatrial septum. AJR Am J Roentgenol (2010) 0.78
Chronic cutaneous fusariosis. Arch Dermatol (2005) 0.78